NO20084253L - Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon - Google Patents

Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon

Info

Publication number
NO20084253L
NO20084253L NO20084253A NO20084253A NO20084253L NO 20084253 L NO20084253 L NO 20084253L NO 20084253 A NO20084253 A NO 20084253A NO 20084253 A NO20084253 A NO 20084253A NO 20084253 L NO20084253 L NO 20084253L
Authority
NO
Norway
Prior art keywords
memory function
tetrahydroisoquinoline derivatives
improve memory
tetrahydroisoquinoline
derivatives
Prior art date
Application number
NO20084253A
Other languages
English (en)
Norwegian (no)
Inventor
Francois Jenck
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of NO20084253L publication Critical patent/NO20084253L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20084253A 2006-03-15 2008-10-10 Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon NO20084253L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2006050812 2006-03-15
PCT/IB2007/050868 WO2007105177A1 (fr) 2006-03-15 2007-03-14 Dérivés de tétrahydroisoquinoléine pour renforcer la fonction de la mémoire

Publications (1)

Publication Number Publication Date
NO20084253L true NO20084253L (no) 2008-10-10

Family

ID=38181192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084253A NO20084253L (no) 2006-03-15 2008-10-10 Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon

Country Status (16)

Country Link
US (1) US20090082394A1 (fr)
EP (1) EP1998774A1 (fr)
JP (3) JP4582722B2 (fr)
KR (1) KR101065239B1 (fr)
CN (1) CN101400348A (fr)
AU (1) AU2007226203A1 (fr)
BR (1) BRPI0708913A2 (fr)
CA (1) CA2644010A1 (fr)
CR (1) CR10260A (fr)
EA (1) EA015256B1 (fr)
IL (1) IL194044A0 (fr)
MA (1) MA30327B1 (fr)
MX (1) MX2008011647A (fr)
NO (1) NO20084253L (fr)
UA (1) UA93903C2 (fr)
WO (1) WO2007105177A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118548A1 (fr) 2004-03-01 2005-12-15 Actelion Pharmaceuticals Ltd Derives de 1,2,3,4-tétrahydroisoquinoléine substitués
JP4582722B2 (ja) * 2006-03-15 2010-11-17 アクテリオン ファーマシューティカルズ リミテッド 記憶機能を向上させるテトラヒドロイソキノリン誘導体
CA2647077A1 (fr) * 2006-04-26 2007-11-01 Actelion Pharmaceuticals Ltd Nouveaux derives de pyrazolo-tetrahydropyridine
WO2008078291A1 (fr) 2006-12-22 2008-07-03 Actelion Pharmaceuticals Ltd Dérivés de 5,6,7,8-tétrahydro-imidazo[1,5-a]pyrazine
WO2008122513A1 (fr) * 2007-04-04 2008-10-16 F. Hoffmann-La Roche Ag Composés hétérocycliques en tant qu'antagonistes des récepteurs d'orexine
PE20091010A1 (es) * 2007-10-10 2009-08-08 Actelion Pharmaceuticals Ltd Derivados de tetrahidroquinolina
WO2009079637A1 (fr) 2007-12-18 2009-06-25 Concert Pharmaceuticals, Inc. Dérivés de tétrahydroisoquinoline
CA2709694C (fr) 2007-12-28 2016-04-05 Actelion Pharmaceuticals Ltd Compose 3,4-dihydro-1h-isoquinoleine trisubstituee, methode de preparation, et son utilisation
EP2307417A2 (fr) 2008-06-25 2011-04-13 Actelion Pharmaceuticals Ltd. Composés de 5,6,7,8-tétrahydro-imidazo[1,5-a]pyrazine
WO2010095106A1 (fr) 2009-02-20 2010-08-26 Actelion Pharmaceuticals Ltd Formes solides de chlorhydrate de( 2r)-2-{(is)-6, 7-diméthoxy- 1-[2- (4-trifluorométhyl-phényl)-éthyl]-3, 4-dihydro-1h-isoquinolin-2-yl}-n-méthyl-2-phényl acétamide
EP2608787B1 (fr) 2010-08-24 2019-11-20 Idorsia Pharmaceuticals Ltd Dérivés de proline sulfonamide comme antagonistes des récepteurs de l'orexine
UA108510C2 (en) 2010-09-22 2015-05-12 Eisai R&D Man Co Ltd Cyclopropane compound
WO2012063207A1 (fr) 2010-11-10 2012-05-18 Actelion Pharmaceuticals Ltd Dérivés de lactame utiles en tant qu'antagonistes du récepteur de l'orexine
WO2012085852A1 (fr) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-8-ylamides
JP5987005B2 (ja) 2011-02-18 2016-09-06 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd オレキシン拮抗薬として有用な新規なピラゾール及びイミダゾール誘導体
WO2012114252A1 (fr) 2011-02-21 2012-08-30 Actelion Pharmaceuticals Ltd Nouveaux amides d'indole et de pyrrolopyridine
WO2013050938A1 (fr) 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd Dérivés de 3,7-diazabicyclo[3.3.1]nonane et de 9-oxa-3,7- diazabicyclo[3.3.1]nonane
DK2776430T3 (en) 2011-11-08 2016-05-09 Actelion Pharmaceuticals Ltd 2- (1,2,3-triazol-2-yl) benzamide and 3- (1,2,3-triazol-2-yl) PICOLINAMIDDERIVATER AS orexin receptor antagonists
US9732075B2 (en) 2012-06-04 2017-08-15 Idorsia Pharmaceuticals Ltd Benzimidazole-proline derivatives
JP6244365B2 (ja) 2012-10-10 2017-12-06 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd [オルトビ−(ヘテロ−)アリール]−[2−(メタビ−(ヘテロ−)アリール)−ピロリジン−1−イル]−メタノン誘導体であるオレキシン受容体アンタゴニスト
WO2014141065A1 (fr) 2013-03-12 2014-09-18 Actelion Pharmaceuticals Ltd Dérivés d'amide d'azétidine en tant qu'antagonistes des récepteurs d'oréxine
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
SI3077389T1 (en) 2013-12-03 2018-01-31 Idorsia Pharmaceuticals Ltd (S) - (2- (6-CHLORO-7-METHYL-1 H-BENZO (D) IMIDAZOL-2-YL) -2-METHYLPYROLIDIN-1-YL (5-METHOXY-2- (2H- , 2,3-TRIAZOL-2-IL) PHENYL) METHANONE AND ITS USE AS ANTAGONISTS OF OREXIN RECEPTOR
WO2015083094A1 (fr) 2013-12-04 2015-06-11 Actelion Pharmaceuticals Ltd Utilisation de dérivés de benzimidazole-proline
US10188652B2 (en) 2014-10-23 2019-01-29 Eisai R&D Management Co., Ltd. Compositions and methods for treating insomnia
WO2020007964A1 (fr) 2018-07-05 2020-01-09 Idorsia Pharmaceuticals Ltd Dérivés de 2-(2-azabicyclo [3.1.0] hexan-1-yl)-1h-benzimidazole
WO2020007977A1 (fr) 2018-07-06 2020-01-09 Idorsia Pharmaceuticals Ltd Dérivés de 7-trifluorométhyl-[1,4]diazépane
WO2020099511A1 (fr) 2018-11-14 2020-05-22 Idorsia Pharmaceuticals Ltd Dérivés de benzimidazole-2-méthyl-morpholine
TW202400149A (zh) 2022-05-13 2024-01-01 瑞士商愛杜西亞製藥有限公司 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2703050B1 (fr) * 1993-03-24 1995-04-28 Adir Nouveaux dérivés bicycliques azotés, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
GB9319732D0 (en) * 1993-09-24 1993-11-10 Ucb Sa Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety
JP3942207B2 (ja) * 1995-02-17 2007-07-11 武田薬品工業株式会社 うつ性症状改善剤
ES2234840T3 (es) * 2000-03-14 2005-07-01 Actelion Pharmaceuticals Ltd. Derivados de 1,2,3,4- tetrahidroisoquinolina.
EP1288202A4 (fr) * 2000-05-11 2003-07-02 Banyu Pharma Co Ltd Derives n-acyltetrahydroisoquinoline
WO2002051232A2 (fr) * 2000-12-27 2002-07-04 Actelion Pharmaceuticals Ltd. Nouvelles benzazepines et derives heterocycliques associes
NZ535885A (en) * 2002-04-26 2007-05-31 Hoffmann La Roche Isoquinoline derivatives and their use as monoamine oxidase B inhibitors
WO2004085403A1 (fr) 2003-03-26 2004-10-07 Actelion Pharmaceuticals Ltd Derives de tetrahydro-isoquinolyl-acetamide destines a servir d'antagonistes des recepteurs d'orexine
WO2005118548A1 (fr) * 2004-03-01 2005-12-15 Actelion Pharmaceuticals Ltd Derives de 1,2,3,4-tétrahydroisoquinoléine substitués
FR2874011B1 (fr) * 2004-08-03 2007-06-15 Sanofi Synthelabo Derives de sulfonamides, leur preparation et leur application en therapeutique
JP4582722B2 (ja) * 2006-03-15 2010-11-17 アクテリオン ファーマシューティカルズ リミテッド 記憶機能を向上させるテトラヒドロイソキノリン誘導体

Also Published As

Publication number Publication date
CN101400348A (zh) 2009-04-01
CA2644010A1 (fr) 2007-09-20
WO2007105177A1 (fr) 2007-09-20
CR10260A (fr) 2008-10-03
EA200870357A1 (ru) 2009-02-27
EA015256B1 (ru) 2011-06-30
EP1998774A1 (fr) 2008-12-10
UA93903C2 (ru) 2011-03-25
US20090082394A1 (en) 2009-03-26
MA30327B1 (fr) 2009-04-01
MX2008011647A (es) 2008-09-22
JP2009530265A (ja) 2009-08-27
AU2007226203A1 (en) 2007-09-20
BRPI0708913A2 (pt) 2011-06-14
JP2010270127A (ja) 2010-12-02
JP4582722B2 (ja) 2010-11-17
JP2010248237A (ja) 2010-11-04
KR20080103597A (ko) 2008-11-27
KR101065239B1 (ko) 2011-09-16
IL194044A0 (en) 2009-09-22

Similar Documents

Publication Publication Date Title
NO20084253L (no) Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon
NO20071095L (no) Hittil ukjente tiofenderivater
NO20082793L (no) Nye tiofenderivater
EA200801758A1 (ru) Лекарственные формы, устойчивые к самовольному изменению
ATE424159T1 (de) Katheter
ATE481383T1 (de) 3-aza-bicycloä3.1.0ühexanderivate
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
AR054507A1 (es) Sistema transdermico de vareniclina
PL2049557T3 (pl) Pochodne 1-(d-glikopiranozylo)-3-(4-cyklopropylofenylometylo)-4-fluorowcoindolu i ich zastosowanie jako inhibitorów sglt
ATE447568T1 (de) Neue pyrinderivate
NO20052887D0 (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
NO20090469L (no) Substituerte piperidiner som oker P53-aktiviteten, og anvendelse derav
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
NO20090596L (no) Antivirale fosfinatforbindelser
WO2008070268A3 (fr) Compositions pharmaceutiques
TW200633992A (en) Biaryloxymethylarenecarboxylic acids
ATE510822T1 (de) Kaliumkanalinhibitoren
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
WO2009023664A3 (fr) Sulfonamides à substitution azépine et diazépine utilisés pour inhiber la 11-bêta-hydroxystéroïde déshydrogénase de type-1
MY139425A (en) Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol
NO20091386L (no) Fenyloksyanilinderivater
WO2007130902A3 (fr) Dérivés de cyclopentane thérapeutiques
CY1110787T1 (el) Νεα μορφινικα παραγωγα
WO2007089743A3 (fr) Inhibiteurs du canal potassique
NO20085267L (no) Derivater av 2-alkoksy -3,4,5-trihydroksy-alkyl amider, fremstilling og anvendelse derav, samt sammensetninger inneholdende samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application